You are currently browsing the category archive for the ‘CRT’ category.

Press release

 

Mechanical thrombectomy improves outcomes in acute ischemic stroke.

 

Joint statement of the European Stroke Organisation (ESO), the European Society  of Minimally Invasive Neurological Therapy (ESMINT) and the European Society of Neuroradiology (ESNR)

 

Stroke results from rupture or interruption of blood flow in brain vessels can lead to devastating consequences for patients, their families and society. Steady progress has been achieved in the last 20 years in stroke treatment through better prevention, establishment of stroke care units and the use of clot-busting drugs (intravenous thrombolysis).

 

Last week, new scientific evidence from four major stroke studies was presented at the International Stroke Conference in Nashville, USA. It proved that rapid mechanical thrombectomy (clot retrieval) improves patient function after acute ischemic stroke. To achieve this benefit, patients were treated by interventional neuroradiologists in stroke centers with multidisciplinary stroke teams. This treatment should be performed as rapidly as possible in conjunction with standard intravenous thrombolysis.

 

ESO, ESMINT and ESNR acknowledge this significant progress in acute stroke treatment and strongly support its application in appropriately selected patients in well equipped stroke centers by properly trained neurointerventionists. Further randomized trials of thrombectomy and more detailed analysis of the current trials will help to optimize patient selection and treatment algorithms.

 

Detailed guidelines on mechanical thrombectomy are currently being prepared by the key European societies involved in acute stroke care. Before these detailed guidelines become available, ESO, ESMINT and ESNR have jointly updated and support the consensus statement on thrombectomy by the ESO-Karolinska Stroke Update (see http://2014.strokeupdate.org/consensus-statement-mechanical-thrombectomy-acute-ischemic-stroke).

Background

 

The European Stroke Organisation (ESO) is a society of stroke physicians, researchers, societies and patient organizations with the goal of optimizing  and harmonizing  the management of stroke in Europe by supporting medical education and stroke projects.

More on www.eso-stroke.org

Contact: esoinfo@eso-stroke.org


The European Society of  Minimally Invasive Neurological Therapy (ESMINT) is a multidisciplinary society of individuals and groups working or training in the field of minimally invasive neurological therapy in geographical Europe. It has been established in order to promote the benefits of minimally invasive neurological therapies through education, training and support for high quality scientific research. 

More on www.esmint.eu

Contact email: office@esmint.eu

 

The European Society of Neuroradiology / ESNR Diagnostic and Interventional is a professional society organising European neuroradiologists. The Society organises Annual Scientific meetings – ESNR Congress, common European Training courses in neuroradiology – European Course of Neuroradiology (ECNR) and is a forum for professional development of European Neuroradiology.

More on www.esnr.org

Contact email : info@esnr.org

 

Advertisements

TICH-2 trial – Tranexamic acid for IntraCerebral Haemorrhage 2

investigator meeting italy , Mantova 19 Nov 2014 hosting Alfonso Ciccone

  • The trial is funded by the NIHR HTA
  • The trial opened in March 2013 and will run until February 2017
  • The University of Nottingham is acting as trial sponsor
  • The trial is live and recruitment is ongoing, with 682 participants so far
  • Start up phase — March 2013
  • Main phase — April 2014
  • New sites welcome in the UK and internationally

For further information please contact us.

Trial Manager: Hayley Foster <hayley.foster@nottingham.ac.uk>
Chief Investigator: Dr Nikola Sprigg <nikola.sprigg@nottingham.ac.uk>
Nottingham Stroke Trials Office:

Starting on 29 May 2013 with many Oral Sessions fresh updates on Stroke Large clinical trials (RCTs)
at 11:25-12:30 Room: Auditorium INTERACT2, STICH II, CHIMES, IST-3, SPS3, next day PC-Trial, RESPECT, ALIAS, PHANTOM-S, ICSS, EVA-3S, STICH II.
lamp

Video Salute – Corriere TV.

 

A survey by the Corriere della Sera on the so-called “Zamboni method” for the treatment of multiple sclerosis has evoked many reactions. Professor Giancarlo Comi, President of the Italian Society of Neurology clarifies his point of view on the matters in controversy, noting that the data currently available suggest that the assumptions underlying the method (which is the unblocking of the jugular veins intravascularly) not have sufficient basis

May anti depressants be helpfull in stroke recovery ? also in non depressed subjects ?

Double blind placebo controlled on benefit of prolonged release Levomilnacipran in ischemic stroke recovery. A phase II RCT sponsored by Pierre Fabre Medicament IRPF. First patient enrolled in France. Up to 90 participating centres, six Italian centres will join the project. Stay tuned.

 

 

 

 

 

The PREvention of VENous Thromboembolism In Hemorrhagic Stroke patients (PREVENTIHS) study started in june.

An Italian national  randomized open label trial, with blind follow on LMWH vs standard care in primary prevention of DVT or PE in hemorrhagic stroke. Coordinated by the Stroke Unit of Perugia University. Enrollement time 2 years planned size for 240 patients.

Participating centres:

Dipartimento di Medicina interna, Varese,

Stroke Unit, Reggio Emilia,

Medicina Interna,Ferrara,

Medicina Interna, Cecina,

Stroke Unit, Mantova,

Medicina Interna Vimercate,

Stroke Unit, Bologna

Unità Ictus San Giovanni Battista, Foligno.